The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Affymetrix's revenue will expand 3.8% and EPS will remain in the red.
The average estimate for revenue is $67.1 million. On the bottom line, the average EPS estimate is -$0.08.
Last quarter, Affymetrix chalked up revenue of $65.2 million. GAAP reported sales were 11% lower than the prior-year quarter's $73.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at -$0.04. GAAP EPS were -$0.06 for Q1 versus $0.00 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 58.1%, 510 basis points worse than the prior-year quarter. Operating margin was -5.1%, 940 basis points worse than the prior-year quarter. Net margin was -6.5%, 660 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $308.8 million. The average EPS estimate is -$0.18.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 349 members out of 412 rating the stock outperform, and 63 members rating it underperform. Among 99 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 87 give Affymetrix a green thumbs-up, and 12 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Affymetrix is hold, with an average price target of $5.38.
Over the decades, small-cap stocks like Affymetrix have provided market-beating returns, provided they're value-priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.
- Add Affymetrix to My Watchlist.